The Special Task Force (STF) of the Crime Branch in Odisha, working in tandem with the Drugs Control Department, has successfully intercepted a large shipment of Wincerex cough syrup, which is based on codeine phosphate, from courier hubs in Cuttack
Zydus Lifesciences Limited (Zydus) signed contracts with PAI and two Amplitude Surgical minority shareholders to purchase blocks of shares, which together account for 85.6% of Amplitude Surgical's voting rights and share capital, for €6.25 per share
The 11th International Exhibition and Healthcare will take place at Bharat Mandapam in New Delhi on September 4–6, 2025. This flagship event, which is organized by the Pharmaceuticals Export Promotion Council of India (Pharmexcil) with assistance
In a significant move toward the Indian pharmaceutical industry, Procter and Gamble (P&G) would invest over Rs 2,000 crore in Gujarat to have a state of the art manufacturing facility of psyllium husk based-Laxative drugs...
The Kingdom of Saudi Arabia (KSA) is contacting Indian pharmaceutical and medical device businesses for strategic partnerships and investment in its quickly growing healthcare sector, which is a significant step towards strengthening bilateral
Novo Nordisk is doubling its India operations as it has launched a major expansion at its Global Business Services (GBS) hub in Bengaluru. In July 2025, the company grew its workforce from 2,500 to over 4,500 employees to reflect its strategy...
Torrent Pharmaceuticals is preparing to launch semaglutide, both oral and injectable, once the patent for the drug expires in early 2026. This positions Torrent as one of the initial entries in the race for India's pharmaceutical players to get...
Akums Drugs & Pharmaceuticals Ltd., India’s largest contract manufacturing pharmaceutical company, is proud to announce that its Sterile Manufacturing Plant has received the prestigious Good Manufacturing Practice(GMP) Certificate from ANVISA...
India's drug and pharmaceutical exports have increased by 92%, from Rs 1,28,028 crore in FY2018-19 to Rs 2,45,962 crore in FY2024-25, thanks to a number of initiatives the Center is implementing to realize the vision of Aatmanirbhar Bharat
Discover how contract pharmaceutical manufacturers can tap into the booming weight-loss drug market. Explore CDMO strategies, regulatory trends, and GLP-1 production insights for 2025 and beyond.
, CDSCO.jpg)
